Optimization of the EC26-2A4 Epitope in the gp41 Membrane Proximal External Region Targeted by Neutralizing Antibodies from an Elite Controller-Reference-Cited by-同舟云学术

Optimization of the EC26-2A4 Epitope in the gp41 Membrane Proximal External Region Targeted by Neutralizing Antibodies from an Elite Controller

Published:2018-04 Issue:4 Volume:34 Page:365-374
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Ringel Oliver¹,Müller Karsten¹²,Koch Joachim¹,Brill Boris¹,Wolf Timo²,Stephan Christoph²,Vieillard Vincent³,Debré Patrice³,Dietrich Ursula¹

Affiliation:

1. Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.

2. Department of Infectious Diseases, HIV Center, University Hospital, Frankfurt, Germany.

3. Sorbonne Universités, UPMC Univ Paris 06, INSERM U1135, CNRS ERL8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2017.0250

Reference77 articles.

1. Antibody-based protection against HIV infection by vectored immunoprophylaxis

2. A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges

3. Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques

4. Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus

5. Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcription Factor ZNF683 Inhibits SIV/HIV Replication through Regulating IFNγ Secretion of CD8+ T Cells;Viruses;2022-03-30

2. Peptides for Vaccine Development;ACS Applied Bio Materials;2022-02-23

3. Antibody response against selected epitopes in the HIV-1 envelope gp41 ectodomain contributes to reduce viral burden in HIV-1 infected patients;Scientific Reports;2021-04-26

4. Peptides to combat viral infectious diseases;Peptides;2020-12

5. DNA adjuvant Amiloride conjunct long immunization interval promote higher antibody responses to HIV-1 gp41 and gp140 immunogens;Vaccine;2020-11